se-methyl-seleno-l-cysteine
Small moleculeexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2007 (NCT00489372)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 3-(methylseleno)alanine
- l-methyl-selenocysteine
- methylselenocysteine
- methylselenocysteine
- methylselenocysteine
- methylselenocysteine
- methyl selenocysteine
- selenohomocysteine
- selenomethylselenocysteine
- selenomethylselenocysteine, (d,l)-isomer
- selenomethylselenocysteine, (l)-isomer
- selenomethylselenocysteine, (l)-isomer, 75se-labeled
- semcys
- se-methylselenocysteine
- se-methyl-selenocysteine
- se-methyl-seleno-l-cysteine
- se-methyl-seleno-l-cysteine
- se-methyl-seleno-l-cysteine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01497431 | Phase 1 | Nov 1, 2011 | National Cancer Institute (NCI), Northwestern University |
| NCT01611038 | N/A | Oct 1, 2011 | Rutgers University, University of Medicine and Dentistry of New Jersey |
| NCT00829205 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2009 | Cancer Research UK, University of London |
| NCT00489372 | Phase 1 | Jul 1, 2007 | National Cancer Institute (NCI), Northwestern University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 2 | 1 | 2007 |
| Northwestern University | Academic/Hospital | 2 | 0 | 1 | 2007 |
| Cancer Research UK | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Rutgers University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Medicine and Dentistry of New Jersey | Academic/Hospital | 1 | 1 | 1 | 2011 |
6 organizations
Page 1 / 1